6:17 PM
 | 
Jun 28, 2007
 |  BC Extra  |  Financial News

EndoCeutics pulls IPO

EndoCeutics (Quebec City, Quebec) withdrew its IPO, citing market conditions and undisclosed changes made to its clinical trials schedule. In May, the company said it would start a Phase III trial next...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >